Latest News about NVO

Recent news which mentions NVO

...

26 27 28 29 30 31 32 33 Next >

Here's Why Demand for Ozempic and Wegovy Could Soar Even Higher

June 08, 2024

Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm

June 08, 2024

10 Health Care Stocks With Whale Alerts In Today's Session

June 07, 2024

Over 10,000 Lawsuits In Novo Nordisk's Ozempic Case Assigned to New Judge

June 07, 2024

ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential

June 07, 2024

Ozempic, Wegovy Create Domino Effect As New Products Emerge Across Industries To Capture New Consumer Habits

June 07, 2024

The 3 Most Undervalued Pharma Stocks to Buy in June 2024

June 06, 2024

Novo Nordisk's Options Frenzy: What You Need to Know

June 06, 2024

Is Viking Therapeutics Stock a Buy on the Dip?

June 06, 2024

Ozempic Just Got Even More Bullish For Novo Nordisk Stock, Yet Again

June 06, 2024

Chinese Generic Ozempic, Wegovy Versions Could Put Novo Nordisk At The Risk Of Stiff Competition In Key Market

June 05, 2024

Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential

June 05, 2024

British Agency Supports Eli Lilly's Weight Loss Drug Mounjaro, Diverging From Restrictions on Rival Novo Nordisk's Wegovy

June 05, 2024

Here Are 3 More Reasons to Be Bullish on Ozempic and Novo Nordisk Stock

June 04, 2024

$100 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today

June 03, 2024

Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030

June 02, 2024

Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger Growth Driver in the Long Run

June 02, 2024

This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors

June 01, 2024

Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes

May 31, 2024

Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing

May 31, 2024

New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk

May 30, 2024

Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead: Goldman Sachs

May 30, 2024

Jim Cramer Recommends Buying Apple, Finds This Tech Stock 'Very Interesting'

May 29, 2024

Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply

May 29, 2024

A New Name in Weight Loss Drugs

May 28, 2024

Novo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health System

May 28, 2024

OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF

May 28, 2024

Ozempic Maker Novo Nordisk's Increasing Influence On Denmark's Employment Raises Economic Concerns

May 28, 2024

Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?

May 28, 2024

The Penny Stock Prophecy: 3 Overlooked Stocks Primed to Pop

May 27, 2024

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.